Are there genetic or immune causes of bronchiectasis? 

Yes, many cases of bronchiectasis are caused by underlying genetic conditions or immune system deficiencies that impair the body’s ability to clear mucus or fight off respiratory infections. 

What We’ll Discuss in This Article 

• How genetic mutations like cystic fibrosis lead to lung damage 

• The impact of Primary Ciliary Dyskinesia on mucus clearance 

• Why antibody deficiencies make the lungs vulnerable to bacteria 

• The link between autoimmune conditions and airway widening 

• How Alpha-1 Antitrypsin deficiency affects lung structure 

• The importance of identifying these causes for targeted treatment 

Genetic causes of bronchiectasis 

In some individuals, bronchiectasis is a secondary symptom of a genetic condition present from birth. These conditions often affect how the body produces mucus or how it moves that mucus out of the airways. Because these issues are built into the person’s DNA, they often lead to symptoms that start in childhood or early adulthood and affect both lungs equally. 

• Cystic Fibrosis (CF): The most well-known genetic cause, where a mutation causes the body to produce extremely thick, sticky mucus that clogs the bronchi. 

• Primary Ciliary Dyskinesia (PCD): A condition where the tiny hairs (cilia) that sweep mucus out of the lungs are shaped incorrectly or do not move at all. 

• Alpha-1 Antitrypsin Deficiency: A genetic lack of a protective protein that prevents the lungs from being damaged by their own inflammatory enzymes. 

Genetic Condition	Biological Mechanism	Impact on Lungs
Cystic Fibrosis	Abnormal salt/water transport	Thick mucus plugs and chronic infection
PCD	Cilia immotility	Failure of the natural cleaning system
Alpha-1 Deficiency	Loss of protein protection	Breakdown of airway and air sac walls
Primary Immunodeficiency	Lack of protective antibodies	Recurring, severe bacterial infections

Immune system deficiencies 

The immune system is the lungs’ primary defence against the bacteria that cause bronchiectasis-related infections. If a person is born with an immune deficiency, particularly one that affects the production of antibodies (immunoglobulins), their lungs are constantly under attack. Without enough antibodies like IgG, IgA, or IgM, common bacteria can settle in the airways and cause the repeated, deep infections that eventually lead to permanent widening. 

• Common Variable Immunodeficiency (CVID): A condition where the body produces very low levels of protective antibodies. 

• Selective IgA Deficiency: A lack of the specific antibody that protects the lining of the respiratory tract. 

• Hypogammaglobulinemia: A general term for low antibody levels that lead to frequent chest infections. 

Autoimmune and systemic conditions 

Sometimes, the immune system causes bronchiectasis not by being weak, but by being overactive. In autoimmune conditions, the body’s immune cells mistakenly attack healthy lung tissue. This chronic internal attack leads to permanent inflammation and scarring of the bronchial walls. 

• Rheumatoid Arthritis: A significant number of people with this joint condition also develop bronchiectasis due to systemic inflammation. 

• Sjogren’s Syndrome: An autoimmune disease that affects moisture-producing glands and can lead to dry, damaged airways. 

• Inflammatory Bowel Disease (IBD): Conditions like Ulcerative Colitis or Crohn’s disease are occasionally linked to airway inflammation and widening. 

Why identifying the cause matters 

Diagnosing a genetic or immune cause is a critical step in managing bronchiectasis. If the underlying issue is an antibody deficiency, for example, the patient may receive regular infusions of immunoglobulins to strengthen their defences. If the cause is cystic fibrosis, specific medications that target the genetic mutation can be used. Without treating the root cause, the lung damage will likely continue to progress regardless of how much mucus is cleared. 

• Prevents further unnecessary damage by treating the root issue 

• Allows for genetic counselling for other family members 

• Guides the use of specialist long-term medications 

• Helps clinicians predict the likely progression of the disease 

To Summarise 

Bronchiectasis is frequently driven by genetic factors or flaws in the immune system. Conditions like cystic fibrosis and PCD prevent the lungs from clearing mucus, while antibody deficiencies leave the airways unprotected against bacterial invasion. Identifying these underlying causes through blood and genetic testing is essential for providing the correct treatment and stopping the cycle of recurring infections and permanent lung damage. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot 

This article was written by our Medical Content Team and reviewed by Dr. Stefan Petrov to ensure clinical accuracy. It explores the complex genetic and immunological drivers of bronchiectasis according to UK medical standards. Our focus is on helping patients understand the importance of diagnostic testing in uncovering the root cause of their respiratory symptoms. 

Dr. Stefan Petrov is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.